Alembic Pharmaceuticals Ltd. - Research Center
533573 APLLTD Group (A) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
2,811.11 |
2,531.67 |
2,537.14 |
2,459.46 |
2,658.44 |
Operating profit |
373.19 |
270.92 |
540.53 |
513.93 |
879.49 |
Interest |
29.68 |
20.75 |
10.23 |
6.44 |
8.42 |
Gross profit |
364.31 |
251.17 |
576.83 |
510.93 |
874.07 |
EPS (Rs) |
11.77 |
4.94 |
22.64 |
17.76 |
33.93 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
20.80 |
1.00 |
46.53 |
3.45 |
3.00 |
Stock adjustment |
-37.27 |
12.49 |
7.04 |
11.37 |
-25.97 |
Raw material |
748.06 |
608.72 |
577.69 |
534.06 |
579.59 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
653.87 |
534.39 |
499.80 |
528.39 |
499.73 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
1,073.26 |
1,105.15 |
912.09 |
871.71 |
725.60 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
132.94 |
133.56 |
91.29 |
88.03 |
72.55 |
Taxation |
- |
20.56 |
40.60 |
73.86 |
134.59 |
Net profit / loss |
231.37 |
97.05 |
444.95 |
349.05 |
666.93 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
39.31 |
39.31 |
39.31 |
39.31 |
39.31 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
13.28 |
10.70 |
21.30 |
20.90 |
33.08 |
GPM (%) |
12.86 |
9.92 |
22.33 |
20.75 |
32.84 |
NPM (%) |
8.17 |
3.83 |
17.22 |
14.17 |
25.06 |